-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
According to a recent study, researchers have developed an experimental influenza vaccine that can protect animals from various seasonal and pandemic influenza strains.
A study was published in the March 24 issue of the journal Nature, examining in detail the design of new influenza vaccines and how they protect mice, ferrets and non-human primates.
It is estimated that the current influenza virus causes 290,000-650,000 deaths.
In order to create an improved version of the flu vaccine, the research team linked hemagglutinin proteins from four different influenza viruses to customized protein nanoparticles.
Ellis said: "Our vaccine is really very responsive to strain-matched viruses, and the additional coverage we have seen against unmatched strains can reduce the risk of flu season.
Information source: Nanoparticle flu vaccine blocks seasonal and pandemic strains
Original source: Seyhan Boyoglu-Barnum, Daniel Ellis, Rebecca A.